|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade accounts receivable, less allowance for credit losses of $80 and $80, respectively | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Deferred contract costs, net | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Current portion of notes payable, net of unamortized debt issuance costs | ||||||||||||||||||||
| Revolving loan | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued wages and bonuses | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Notes payable, net of current portion and unamortized debt issuance costs | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Contingent consideration, net of current portion | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued | ||||||||||||||||||||
| Common stock, $0.001 par value; authorized 110,000,000 shares, issued 31,975,649 in 2026 and 31,966,504 in 2025, outstanding 22,139,315 in 2026 and 22,637,252 in 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings (accumulated deficit) | ||||||||||||||||||||
| Treasury stock, at cost; 6,394,411 and 6,294,008 common stock in 2023 and 2022, respectively | ||||||||||||||||||||
| Accumulated other comprehensive loss, foreign currency translation adjustment | ||||||||||||||||||||
| Treasury stock, at cost; 9,836,334 and 9,329,252 Common shares in 2026 and 2025, respectively | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity |
Loading...
